281 related articles for article (PubMed ID: 31509308)
1. Astrocytes enhance glioblastoma growth.
Mega A; Hartmark Nilsen M; Leiss LW; Tobin NP; Miletic H; Sleire L; Strell C; Nelander S; Krona C; Hägerstrand D; Enger PØ; Nistér M; Östman A
Glia; 2020 Feb; 68(2):316-327. PubMed ID: 31509308
[TBL] [Abstract][Full Text] [Related]
2. Novel insights into astrocyte-mediated signaling of proliferation, invasion and tumor immune microenvironment in glioblastoma.
Zhang H; Zhou Y; Cui B; Liu Z; Shen H
Biomed Pharmacother; 2020 Jun; 126():110086. PubMed ID: 32172060
[TBL] [Abstract][Full Text] [Related]
3. Pre-Clinical Drug Testing in 2D and 3D Human In Vitro Models of Glioblastoma Incorporating Non-Neoplastic Astrocytes: Tunneling Nano Tubules and Mitochondrial Transfer Modulates Cell Behavior and Therapeutic Respons.
Civita P; M Leite D; Pilkington GJ
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795330
[TBL] [Abstract][Full Text] [Related]
4. A co-culture model with brain tumor-specific bioluminescence demonstrates astrocyte-induced drug resistance in glioblastoma.
Yang N; Yan T; Zhu H; Liang X; Leiss L; Sakariassen PØ; Skaftnesmo KO; Huang B; Costea DE; Enger PØ; Li X; Wang J
J Transl Med; 2014 Oct; 12():278. PubMed ID: 25280402
[TBL] [Abstract][Full Text] [Related]
5. Coculture with astrocytes reduces the radiosensitivity of glioblastoma stem-like cells and identifies additional targets for radiosensitization.
Rath BH; Wahba A; Camphausen K; Tofilon PJ
Cancer Med; 2015 Nov; 4(11):1705-16. PubMed ID: 26518290
[TBL] [Abstract][Full Text] [Related]
6. Reactive astrocytes potentiate tumor aggressiveness in a murine glioma resection and recurrence model.
Okolie O; Bago JR; Schmid RS; Irvin DM; Bash RE; Miller CR; Hingtgen SD
Neuro Oncol; 2016 Dec; 18(12):1622-1633. PubMed ID: 27298311
[TBL] [Abstract][Full Text] [Related]
7. EMT-like process in glioblastomas and reactive astrocytes.
Iser IC; Lenz G; Wink MR
Neurochem Int; 2019 Jan; 122():139-143. PubMed ID: 30496766
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal transition and increased therapy resistance of glioblastoma cells is related to astrocyte reactivity.
Niklasson M; Bergström T; Jarvius M; Sundström A; Nyberg F; Haglund C; Larsson R; Westermark B; Segerman B; Segerman A
J Pathol; 2019 Nov; 249(3):295-307. PubMed ID: 31298733
[TBL] [Abstract][Full Text] [Related]
9. Glioma-astrocyte interactions on white matter tract-mimetic aligned electrospun nanofibers.
Grodecki J; Short AR; Winter JO; Rao SS; Winter JO; Otero JJ; Lannutti JJ; Sarkar A
Biotechnol Prog; 2015; 31(5):1406-15. PubMed ID: 26081199
[TBL] [Abstract][Full Text] [Related]
10. SYK inhibition blocks proliferation and migration of glioma cells and modifies the tumor microenvironment.
Moncayo G; Grzmil M; Smirnova T; Zmarz P; Huber RM; Hynx D; Kohler H; Wang Y; Hotz HR; Hynes NE; Keller G; Frank S; Merlo A; Hemmings BA
Neuro Oncol; 2018 Apr; 20(5):621-631. PubMed ID: 29401256
[TBL] [Abstract][Full Text] [Related]
11. Platelet-derived growth factor receptor α/glial fibrillary acidic protein expressing peritumoral astrocytes associate with shorter median overall survival in glioblastoma patients.
Leiss L; Mega A; Olsson Bontell T; Nistér M; Smits A; Corvigno S; Rahman MA; Enger PØ; Miletic H; Östman A
Glia; 2020 May; 68(5):979-988. PubMed ID: 31769546
[TBL] [Abstract][Full Text] [Related]
12. Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation.
Xia S; Lal B; Tung B; Wang S; Goodwin CR; Laterra J
Neuro Oncol; 2016 Apr; 18(4):507-17. PubMed ID: 26320116
[TBL] [Abstract][Full Text] [Related]
13. Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma.
Luedi MM; Singh SK; Mosley JC; Hassan ISA; Hatami M; Gumin J; Andereggen L; Sulman EP; Lang FF; Stueber F; Fuller GN; Colen RR; Zinn PO
J Neurosurg; 2018 Dec; 129(6):1446-1455. PubMed ID: 29328002
[TBL] [Abstract][Full Text] [Related]
14. SH3BGRL2 functions as a crucial tumor suppressor in glioblastoma tumorigenesis.
Nie Z; Cai S; Wei Z; Li Y; Bian L; Wang C; Wang C
Biochem Biophys Res Commun; 2021 Apr; 547():148-154. PubMed ID: 33610914
[TBL] [Abstract][Full Text] [Related]
15. Microenvironment involved in FPR1 expression by human glioblastomas.
Boer JC; van Marion DM; Joseph JV; Kliphuis NM; Timmer-Bosscha H; van Strijp JA; de Vries EG; den Dunnen WF; Kruyt FA; Walenkamp AM
J Neurooncol; 2015 May; 123(1):53-63. PubMed ID: 25894595
[TBL] [Abstract][Full Text] [Related]
16. High-capacity glycolytic and mitochondrial oxidative metabolisms mediate the growth ability of glioblastoma.
Kim J; Han J; Jang Y; Kim SJ; Lee MJ; Ryu MJ; Kweon GR; Heo JY
Int J Oncol; 2015 Sep; 47(3):1009-16. PubMed ID: 26202438
[TBL] [Abstract][Full Text] [Related]
17. KCa3.1 channels are involved in the infiltrative behavior of glioblastoma in vivo.
D'Alessandro G; Catalano M; Sciaccaluga M; Chece G; Cipriani R; Rosito M; Grimaldi A; Lauro C; Cantore G; Santoro A; Fioretti B; Franciolini F; Wulff H; Limatola C
Cell Death Dis; 2013 Aug; 4(8):e773. PubMed ID: 23949222
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
[TBL] [Abstract][Full Text] [Related]
19. Hybrids by tumor-associated macrophages × glioblastoma cells entail nuclear reprogramming and glioblastoma invasion.
Cao MF; Chen L; Dang WQ; Zhang XC; Zhang X; Shi Y; Yao XH; Li Q; Zhu J; Lin Y; Liu S; Chen Q; Cui YH; Zhang X; Bian XW
Cancer Lett; 2019 Feb; 442():445-452. PubMed ID: 30472185
[TBL] [Abstract][Full Text] [Related]
20. Microglial lysophosphatidic acid promotes glioblastoma proliferation and migration via LPA
Amaral RF; Geraldo LHM; Einicker-Lamas M; E Spohr TCLS; Mendes F; Lima FRS
J Neurochem; 2021 Feb; 156(4):499-512. PubMed ID: 32438456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
